SciClone Pharmaceuticals Inc (NASDAQ:SCLN) - Share price - Overview

Stock Report

SciClone Pharmaceuticals Inc SCLN

Last Price
$-

Day Change
-|-%

As of -
- | USD
Minimum 15 Minutes Delay.

Last Close-
Day Range-
Mkt Cap581.90Mil
52-Wk Range-
Yield %-
ISINUS80862K1043
Volume-
P/E-
P/S-
P/CF-

Share Price

Financials
201420152016
More ...
Income Statement
Revenue134.79157.26160.10
Operating Income25.9829.9133.24
Net Income25.2129.4630.73
Basic EPS0.490.590.61
Avg. Diluted Shares Outstanding535253
Balance Sheet
Current Assets140.20168.52195.73
Non Current Assets41.6348.1046.17
Total Assets181.83216.62241.90
Current Liabilities26.4436.8226.44
Total Liabilities26.5636.9126.53
Total Equity155.27179.71215.37
Cash Flow
Operating Cash Flow27.6132.5134.53
Capital Expenditure-1.45-1.84-0.65
Free Cash Flow26.1630.6733.88

In millions, except "Basic EPS". Currency is USD.

Company Profile

SciClone Pharmaceuticals Inc is a specialty pharmaceutical company with a substantial commercial business in China and a product portfolio of therapies for oncology, infectious diseases and cardiovascular disorders.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Stock Style

Small-Blend

Fiscal Year Ends

December

Employees

570
Key Stats
More ...
Price/Earning TTM-
Price/Book-
Price/Sales TTM-
Rev Growth (3 year avg)8.01
EPS Growth (3 year avg)-
Operating Margin % TTM20.76
Net Margin % TTM19.19
ROE TTM15.56
Debt/Equity-
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.